Sentry LLC Immuno Precise Antibodies Ltd. Transaction History
Sentry LLC
- $502 Billion
- Q2 2025
A detailed history of Sentry LLC transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Sentry LLC holds 10,000 shares of IPA stock, worth $20,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$20,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IPA
# of Institutions
25Shares Held
3.95MCall Options Held
27.2KPut Options Held
0-
Ingalls & Snyder LLC New York, NY2.78MShares$5.56 Million0.1% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA703KShares$1.41 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY90.6KShares$181,1640.0% of portfolio
-
Virtu Financial LLC New York, NY57.8KShares$115,6940.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$82,4000.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $49.7M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...